Publicaciones en colaboración con investigadores/as de Centro Nacional de Biotecnología (44)

2024

  1. MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses

    Frontiers in Immunology, Vol. 15

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  3. Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2

    Advanced Science, Vol. 10, Núm. 34

  4. Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver

    Molecular Genetics and Metabolism Reports, Vol. 35

  5. NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells

    Frontiers in Immunology, Vol. 14

  6. N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile

    Journal of Medicinal Chemistry, Vol. 66, Núm. 8, pp. 5465-5483

  7. Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters

    Frontiers in Immunology, Vol. 14

  8. Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates

    Frontiers in Immunology, Vol. 14

2022

  1. A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection

    Frontiers in Immunology, Vol. 12

  2. Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice

    npj Vaccines, Vol. 7, Núm. 1

  3. Infusion of haploidentical NKG2D-CAR-TCD45RA- cells in two pediatric patients with advanced relapsed and refractory acute leukemia was safe but achieved no clinical benefits

    Leukemia and Lymphoma

  4. Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection

    Frontiers in Immunology, Vol. 13

  5. Molecular Classification of Colorectal Cancer by microRNA Profiling: Correlation with the Consensus Molecular Subtypes (CMS) and Validation of miR-30b Targets

    Cancers, Vol. 14, Núm. 21

  6. New insights into the role of endosomal proteins for African swine fever virus infection

    PLoS Pathogens, Vol. 18, Núm. 1

  7. Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2

    Frontiers in Immunology, Vol. 13

  8. Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19

    Life science alliance, Vol. 5, Núm. 4

2021

  1. Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses

    Antiviral Research, Vol. 186

  2. Intracoronary delivery of porcine cardiac progenitor cells overexpressing igf-1 and hgf in a pig model of sub-acute myocardial infarction

    Cells, Vol. 10, Núm. 10

2020

  1. SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells

    Journal for immunotherapy of cancer, Vol. 8, Núm. 1